David Abramson, MD
Plastic Surgery · Englewood, NJNPI 1720046139
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (44.4%), speaking fees and food and beverage — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by TELA Bio, Inc. at 43.4% of the total.
Across 29 payments — averaging $117.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- TELA Bio, Inc.$1K
- W. L. Gore & Associates, Inc.$900
- Musculoskeletal Transplant Foundation Inc.$558
- AbbVie$181
- Integra Lifesciences Corporation$75
- AstraZeneca$65
- plus $146 from 7 others
Across 1 payment — averaging $13,210 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- TELA Bio, Inc.$13K
What the payments were for
- Consulting fees$1,50644%
- Speaking & faculty fees$1,04831%
- Food & beverage$84225%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| TELA Bio, Inc. | 7 | $1,472 |
| W. L. Gore & Associates, Inc. | 1 | $900 |
| Musculoskeletal Transplant Foundation Inc. | 3 | $558 |
| AbbVie(2 entities) | 3 | $181 |
| Integra Lifesciences Corporation | 4 | $75 |
| AstraZeneca | 3 | $65 |
| Convatec Inc. | 2 | $44 |
| Sientra, Inc. | 1 | $23 |
| Motiva USA, LLC | 1 | $19 |
| Daiichi Sankyo Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Merck | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,396 in reported general payments places this provider in the 65th percentile of 170 plastic surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 27 | $141 |
| Cephalexin | 12 | $69 |
Paid to pharmacies, not to this prescriber.
Other plastic surgery in Englewood
- Troy CallahanEnglewood$6K
- Shwetambara ParakhEnglewood$4K
- Julie FerrauiolaEnglewood$3K
- Steven DavisCherry Hill$349K
- Caroline GlicksmanSea Girt$239K
- Asaad SamraHolmdel$224K
- Travis LaverneVoorhees Township$119K
- Joseph RacanelliMorristown$90K
- Fares SamraHolmdel$54K
- Anthony LombardiEatontown$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.